Programming CD8+ T cells for effective immunotherapy
- 30 June 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 18 (3), 363-370
- https://doi.org/10.1016/j.coi.2006.03.009
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Effector and memory CD8+ T cell fate coupled by T-bet and eomesoderminNature Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic VaccinationJournal of Virology, 2005
- Differential contributions of central and effector memory T cells to recall responsesThe Journal of Experimental Medicine, 2005
- Wnt signalling in stem cells and cancerNature, 2005
- Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 InfectionPLoS Biology, 2004
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Role for Bcl-6 in the generation and maintenance of memory CD8+ T cellsNature Immunology, 2002
- A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic MelanomaJournal of Immunotherapy, 2002
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999